Regulatory Affairs Archives - Page 2 of 3

25 Mar 22

HKAPI Regulatory Training Workshop Series – Seminar 5 Medical Devices & Private Healthcare Facilities Ordinance

Seminar 5 - Medical Devices & Private Healthcare Facilities Ordinance Date: 25 March 2022 (Fri) Time: 2:00 pm - 4:30 pm

18 Mar 22

HKAPI Regulatory Training Workshop Series – Seminar 4

Seminar 4 - ATP new product registration & clinical trial applications and Real World Evidence Date: 18 March 2022 (Fri) Time: 4:00 pm- 6:00pm

11 Mar 22

HKAPI Regulatory Training Workshop Series – Seminar 3

Seminar 3 - CORP & e-labelling Date: 11 March 2022 (Fri) Time: 2:00 pm - 4:30 pm

04 Mar 22

HKAPI Regulatory Training Workshop Series – Seminar 2

Seminar 2 - New product registration and Good reliance pathway Date: 4 March 2022 (Fri) Time: 2:00 pm - 4:30 pm

25 Feb 22

HKAPI Regulatory Training Workshop Series – Seminar 1

Seminar 1: 1. Highlights of Regulatory Trends in 2022 2. Counterfeits and Parallel imports in Hong Kong

13 Jan 22

Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

Topic: Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong Speaker: Dr. Daniel Lee, Associate Vice-President (Innovation and Enterprise), The Chinese University of Hong Kong Language: English Target […]

18 Dec 19

New Product Submission and Best Practice Workshop

On December 18, 2019, around 70 members from the regulatory affairs and pharmacovigilance department attended the New Product submission and Best Practice Workshop held at HKU.

17 Oct 19

Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop

About 60 members, non-members and academics turned up for Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop jointly organized by The University of Hong Kong and HKAPI.

30 Apr 19

Regulatory Affairs Sharing Session

On 30 April 2019, the Regulatory Affairs Taskforce (RATF) presented a sharing session to update members on the latest achievements and work in progress in relation to the various regulatory affairs initiatives.

14 Dec 18

Drug Office-HKAPI Joint Briefing Session

On 14 December 2018, a joint briefing session between the Drug Office and HKAPI was held at the Public Health Laboratory Centre in Kowloon. It was overwhelmingly attended by about 90 members, with the majority being Regulatory Affairs staff.

HKAPI Regulatory Training Workshop Series – Seminar 5 Medical Devices & Private Healthcare Facilities Ordinance

HKAPI Regulatory Training Workshop Series – Seminar 4

HKAPI Regulatory Training Workshop Series – Seminar 3

HKAPI Regulatory Training Workshop Series – Seminar 2

HKAPI Regulatory Training Workshop Series – Seminar 1

Introduction of the first Advanced Therapy Product GMP Facility in Hong Kong

New Product Submission and Best Practice Workshop

Product Life Cycle Management from Regulatory Perspective and Best Practice Workshop

Regulatory Affairs Sharing Session

Drug Office-HKAPI Joint Briefing Session

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use